肿瘤细胞治疗研究
DISEASE HUB
FOR TREATMENT
现在就能报名的（招募中）排在最前，共 1 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性，以登记原文和主治医生判断为准。
FOR RESEARCH
Oncolytic zika virus therapy leverages CCR2+ monocytes to boost anti-glioblastoma T cell responses.
ZIKV 驱动的 CCR2+单核细胞活化和募集通过增强细胞毒性和限制耗竭，支持强效的抗肿瘤 CD8+ T 细胞应答。这些发现凸显了调节单核细胞-T 细胞交互作用以克服 GBM 中免疫抑制此前未被认识的治疗潜力。
Next-generation therapeutics for glioblastoma: Challenges and future directions.
Developing a multimodal therapy for glioblastoma using oncolytic virus delivering CD19 and EGFRvIII antigens and bi-specific CARs.
Diffuse intrinsic pontine glioma in the era of H3 K27-altered diffuse midline glioma.
Metabolic dependencies and neural progenitor dysregulation: driving forces in paediatric high-grade glioma development.
Immunosuppressive Tumor Microenvironment and Therapeutic Landscape of Diffuse Intrinsic Pontine Glioma.
Immunotherapy for Glioma: A compartmental framework for resistance and rational combination design.
Persistent T cell activation and cytotoxicity against glioblastoma following single oncolytic virus treatment in a clinical trial.
Advancing chimeric antigen receptor T-cell therapy frontiers in glioblastoma: Navigating the current landscape from clinical hurdles to breakthrough s
MEMBER ACCOUNT
登录成功会直接打开下一页。
